Oxytek Medical is proud to announce that its oxygen concentrator product line has successfully achieved certification under the European Union Medical Device Regulation (MDR) 2017/745.

This achievement marks a significant milestone in the company's ongoing commitment to quality, patient safety, and regulatory excellence. The MDR certification demonstrates that Oxytek Medical's products comply with the European Union's most rigorous and up-to-date medical device requirements.

Meeting the Highest European Regulatory Standards

The MDR (Medical Device Regulation 2017/745) represents the most comprehensive regulatory framework for medical devices in Europe. Compared with the previous Medical Device Directive (MDD), MDR introduces stricter requirements for:

• Clinical evaluation and evidence

• Risk management processes

• Product traceability

• Post-market surveillance

• Quality management systems

• Patient safety and performance monitoring

Successfully obtaining MDR certification confirms that Oxytek Medical has established robust processes throughout the entire product lifecycle, from design and manufacturing to post-market monitoring and continuous improvement.

Strengthening Global Market Competitiveness

With MDR certification, Oxytek Medical is further strengthening its position in the European healthcare market while expanding opportunities in other international regions that recognize European regulatory standards.

The certification enhances confidence among distributors, healthcare providers, and end users by ensuring that Oxytek Medical products meet internationally recognized requirements for safety, quality, and performance.

Commitment to Innovation and Quality

As a professional manufacturer of oxygen therapy solutions, Oxytek Medical remains dedicated to developing reliable, efficient, and patient-friendly oxygen concentrators for homecare and healthcare applications.

The successful MDR certification reflects the company's continuous investment in product development, regulatory compliance, and manufacturing excellence.

"Our mission has always been to provide dependable oxygen therapy solutions that improve patients' quality of life," said the management team of Oxytek Medical. "Obtaining MDR certification is an important recognition of our quality standards and a solid foundation for our continued growth in Europe and other regulated markets."

Looking Ahead

Oxytek Medical will continue to focus on innovation, quality, and customer satisfaction while expanding its global presence. The company remains committed to delivering advanced oxygen therapy solutions that meet the evolving needs of healthcare professionals and patients worldwide.

For more information about Oxytek Medical and its oxygen concentrator product portfolio, please contact our sales team or visit our website.